<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: That type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is known </plain></SENT>
<SENT sid="1" pm="."><plain>However, information is lacking regarding the long-term and adverse changes of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> variables in the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> from childhood to adulthood </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Observations were examined, retrospectively, in a community-based cohort of normoglycemic (n = 1,838), <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> (n = 90), and type 2 diabetic (n = 60) subjects followed serially for <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> during childhood (4-11 years), adolescence (12-18 years), and adulthood (19-44 years) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Diabetic subjects versus normoglycemic subjects had significantly higher levels of subscapular skinfold, BMI, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, and homeostasis model assessment of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and lower levels of <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> beginning in childhood and higher levels of mean arterial pressure (MAP) in adolescence and adulthood </plain></SENT>
<SENT sid="4" pm="."><plain>In a multivariate model including BMI, MAP, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, and insulin, adjusted for age, age(2), race, sex, and race x sex interaction, adverse changes in <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> were independently associated with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> subjects, whereas adverse changes in BMI, <z:chebi fb="105" ids="17234">glucose</z:chebi>, and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> were associated with diabetic subjects </plain></SENT>
<SENT sid="5" pm="."><plain>As young adults, <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> and diabetic groups displayed a significantly higher prevalence of <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: These findings indicate that adverse levels of risk variables of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, and measures of <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis accelerating since childhood characterize the early natural history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and underscore the importance of early prevention and intervention on risk factors beginning in childhood </plain></SENT>
</text></document>